Belite Bio, Inc (BLTE) EBITDA

annual EBITDA:

-$35.67M-$4.47M(-14.33%)
December 31, 2024

Summary

  • As of today (September 20, 2025), BLTE annual EBITDA is -$35.67 million, with the most recent change of -$4.47 million (-14.33%) on December 31, 2024.
  • During the last 3 years, BLTE annual EBITDA has fallen by -$26.03 million (-270.16%).
  • BLTE annual EBITDA is now -524.24% below its all-time high of -$5.71 million, reached on December 31, 2020.

Performance

BLTE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBLTEincome statement metrics

quarterly EBITDA:

-$17.60M-$2.08M(-13.40%)
June 30, 2025

Summary

  • As of today (September 20, 2025), BLTE quarterly EBITDA is -$17.60 million, with the most recent change of -$2.08 million (-13.40%) on June 30, 2025.
  • Over the past year, BLTE quarterly EBITDA has dropped by -$7.13 million (-68.05%).
  • BLTE quarterly EBITDA is now -1571.04% below its all-time high of -$1.05 million, reached on March 31, 2022.

Performance

BLTE quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBLTEincome statement metrics

TTM EBITDA:

-$54.31M-$7.13M(-15.10%)
June 30, 2025

Summary

  • As of today (September 20, 2025), BLTE TTM EBITDA is -$54.31 million, with the most recent change of -$7.13 million (-15.10%) on June 30, 2025.
  • Over the past year, BLTE TTM EBITDA has dropped by -$17.59 million (-47.92%).
  • BLTE TTM EBITDA is now -5057.64% below its all-time high of -$1.05 million, reached on March 31, 2022.

Performance

BLTE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBLTEincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BLTE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.3%-68.0%-47.9%
3 y3 years-270.2%-602.1%-1426.0%
5 y5 years-524.2%--

BLTE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-270.2%at low-592.8%at low-790.5%at low
5 y5-year-524.2%at low-1571.0%at low-5057.6%at low
alltimeall time-524.2%at low-1571.0%at low-5057.6%at low

BLTE EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$17.60M(+13.4%)
-$54.31M(+15.1%)
Mar 2025
-
-$15.52M(+35.4%)
-$47.19M(+18.0%)
Dec 2024
-$35.67M(+14.3%)
-$11.46M(+17.6%)
-$40.00M(+12.7%)
Sep 2024
-
-$9.74M(-7.0%)
-$35.49M(-3.3%)
Jun 2024
-
-$10.47M(+25.7%)
-$36.72M(+10.9%)
Mar 2024
-
-$8.33M(+19.7%)
-$33.12M(+4.6%)
Dec 2023
-$31.20M
-$6.96M(-36.5%)
-$31.67M(+1.4%)
Sep 2023
-
-$10.96M(+59.5%)
-$31.25M(+36.9%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$6.87M(-0.1%)
-$22.82M(+23.6%)
Mar 2023
-
-$6.88M(+5.3%)
-$18.46M(+46.1%)
Dec 2022
-$12.43M(+29.0%)
-$6.53M(+157.2%)
-$12.63M(+107.1%)
Sep 2022
-
-$2.54M(+1.4%)
-$6.10M(+71.4%)
Jun 2022
-
-$2.51M(+138.0%)
-$3.56M(+238.0%)
Mar 2022
-
-$1.05M
-$1.05M
Dec 2021
-$9.64M(+68.6%)
-
-
Dec 2020
-$5.71M
-
-

FAQ

  • What is Belite Bio, Inc annual EBITDA?
  • What is the all time high annual EBITDA for Belite Bio, Inc?
  • What is Belite Bio, Inc annual EBITDA year-on-year change?
  • What is Belite Bio, Inc quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Belite Bio, Inc?
  • What is Belite Bio, Inc quarterly EBITDA year-on-year change?
  • What is Belite Bio, Inc TTM EBITDA?
  • What is the all time high TTM EBITDA for Belite Bio, Inc?
  • What is Belite Bio, Inc TTM EBITDA year-on-year change?

What is Belite Bio, Inc annual EBITDA?

The current annual EBITDA of BLTE is -$35.67M

What is the all time high annual EBITDA for Belite Bio, Inc?

Belite Bio, Inc all-time high annual EBITDA is -$5.71M

What is Belite Bio, Inc annual EBITDA year-on-year change?

Over the past year, BLTE annual EBITDA has changed by -$4.47M (-14.33%)

What is Belite Bio, Inc quarterly EBITDA?

The current quarterly EBITDA of BLTE is -$17.60M

What is the all time high quarterly EBITDA for Belite Bio, Inc?

Belite Bio, Inc all-time high quarterly EBITDA is -$1.05M

What is Belite Bio, Inc quarterly EBITDA year-on-year change?

Over the past year, BLTE quarterly EBITDA has changed by -$7.13M (-68.05%)

What is Belite Bio, Inc TTM EBITDA?

The current TTM EBITDA of BLTE is -$54.31M

What is the all time high TTM EBITDA for Belite Bio, Inc?

Belite Bio, Inc all-time high TTM EBITDA is -$1.05M

What is Belite Bio, Inc TTM EBITDA year-on-year change?

Over the past year, BLTE TTM EBITDA has changed by -$17.59M (-47.92%)
On this page